HSBC HOLDINGS PLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,470,758
-6.0%
256,801
+4.2%
0.00%0.0%
Q2 2023$2,627,512
-0.4%
246,507
-1.5%
0.00%0.0%
Q1 2023$2,636,959
+49.8%
250,157
+76.0%
0.00%
+50.0%
Q4 2022$1,760,439
+154.4%
142,137
+114.8%
0.00%
+100.0%
Q3 2022$692,000
-47.3%
66,175
-41.9%
0.00%
-50.0%
Q2 2022$1,312,000
+358.7%
113,819
+399.2%
0.00%
Q1 2022$286,000
-46.9%
22,800
-50.4%
0.00%
Q4 2021$539,000
-4.8%
45,934
+6.5%
0.00%
-100.0%
Q3 2021$566,000
-19.7%
43,117
-21.0%
0.00%0.0%
Q2 2021$705,000
+142.3%
54,547
+108.6%
0.00%
Q1 2021$291,000
-20.7%
26,149
-18.9%
0.00%
Q4 2020$367,000
+151.4%
32,236
+99.7%
0.00%
Q3 2020$146,000
-64.3%
16,140
-59.3%
0.00%
-100.0%
Q2 2020$409,000
-39.4%
39,649
-21.7%
0.00%0.0%
Q4 2019$675,000
+6.8%
50,624
-31.2%
0.00%0.0%
Q3 2019$632,000
+85.3%
73,593
+230.2%
0.00%0.0%
Q4 2016$341,00022,2870.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders